HighVista Strategies’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,217
| Closed | -$661K | – | 158 |
|
|
2024
Q4 | $661K | Buy |
+4,217
| New | +$661K | 0.25% | 119 |
|
|
2024
Q2 | – | Sell |
-3,923
| Closed | -$698K | – | 145 |
|
|
2024
Q1 | $698K | Buy |
+3,923
| New | +$698K | 0.25% | 106 |
|
|
2023
Q4 | – | Sell |
-4,392
| Closed | -$509K | – | 136 |
|
|
2023
Q3 | $509K | Buy |
4,392
+1,862
| +74% | +$216K | 0.24% | 106 |
|
|
2023
Q2 | $297K | Sell |
2,530
-8,528
| -77% | -$1M | 0.14% | 133 |
|
|
2023
Q1 | $885K | Hold |
11,058
| – | – | 0.72% | 42 |
|
|
2022
Q4 | $876K | Buy |
11,058
+4,023
| +57% | +$319K | 0.52% | 57 |
|
|
2022
Q3 | $490K | Sell |
7,035
-5,190
| -42% | -$361K | 0.28% | 82 |
|
|
2022
Q2 | $803K | Buy |
+12,225
| New | +$803K | 0.48% | 48 |
|